Nikolaj Frost

16PUBLICATIONS
88CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Medical molecular engineering of nucleic acids and proteinsHaematological tumoursPredictive and prognostic markersOncology and carcinogenesis not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Jul 25, 2026
Clinical management and outcomes of relapsed NSCLC after chemoradiotherapy and durvalumab consolidation: real-world evidence from Germany.

|Apr 07, 2026
ADC Target Profiling in NSCLC: Generalizable AI Separates TROP-2 and cMET Phenotypes.

Philipp Anders, Marvin Sextro, Katja Lingelbach

|Mar 27, 2026
Reversal of Paraneoplastic Non-Bacterial Thrombotic Endocarditis with Heparin and Targeted Cancer Therapy: A Case Report.

Collin Goetze, Nikolaj Frost, Ingo Hilgendorf

|Jan 08, 2026
Clinical outcomes with perioperative nivolumab by nodal status in patients with stage III resectable NSCLC: phase 3 CheckMate 77T exploratory analysis.

Mariano Provencio, Mark M Awad, Jonathan D Spicer

|Dec 24, 2025
Independent Validation of a Machine Learning Classifier for Predicting Mediastinal Lymph Node Metastases in Non-Small Cell Lung Cancer Using Routinely Obtainable [18F]FDG-PET/CT Parameters.

Agata Wdowiak, Julian M M Rogasch, Georg L Baumgärtner

|Nov 03, 2025
AI-powered spatial cell phenomics enhances risk stratification in non-small cell lung cancer.

Simon Schallenberg, Gabriel Dernbach, Sharon Ruane

Pageof 3

Frequent Collaborators

3 joint publications

Reinhard Büttner

2 joint publications

Alexander Quaas

2 joint publications

Matthias Heldwein

2 joint publications

Cornelius Böhm